The net profits after tax of Sabaa International for Pharmaceutical and Chemical Industry (SIPC) dropped by 99.73% year-on-year (YoY) to EGP 18,119 in 2022, compared to EGP 6.780 million, according to the firm’s financial results sent to the Egyptian bourse on March 27th.

The pharmaceutical company’s revenues declined to EGP 17.560 million last year from EGP 45.417 million in 2021.

Saba International is an Egypt-based company operating in the pharmaceutical sector, with a generic product portfolio that includes products focused on different therapeutic categories.


Copyright © 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (